Organigram Global (OGI) EBIT Margin (2018 - 2026)
Organigram Global (OGI) posted quarterly EBIT Margin of 15.41% for Q1 2026, down 386.0% year-on-year from 5.39% in Q1 2025, and down 450.65% on a QoQ basis from 2.8% in Q4 2025.
Organigram Global (OGI) EBIT Margin (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported EBIT Margin for 7 consecutive years, with 15.41% the latest figure, recorded in Q1 2026.
- Quarterly EBIT Margin fell 386.0% year-over-year to 15.41% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.43% (up 316.0% YoY) and the FY2025 annual result came in at 4.25%, changed N/A from the prior year.
- EBIT Margin fell to 15.41% in Q1 2026 per OGI's latest filing, from 2.8% in the prior quarter.
- Over the last five years, EBIT Margin for OGI reached as high as 2.8% in Q4 2025 and fell as low as 15.92% in Q4 2024.
- A 3-year average of 11.42% and a median of 13.49% in 2026 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2025 — EBIT Margin jumped 1312 bps — and 2026, when it plunged 386 bps.
- Year by year, EBIT Margin stood at 15.92% in 2024, then surged by 82 bps to 2.8% in 2025, then sank by 451 bps to 15.41% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 15.41%, 2.8%, and 11.56% for Q1 2026, Q4 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn | -15.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.41% |
| Dec 31, 2025 | -2.80% |
| Mar 31, 2025 | -11.56% |
| Dec 31, 2024 | -15.92% |
| May 31, 2021 | -128.37% |
| Feb 28, 2021 | 169.20% |
| Nov 30, 2020 | -145.95% |
| Aug 31, 2020 | -1,219.02% |
| May 31, 2020 | -551.07% |
| Feb 29, 2020 | -17.34% |
| Aug 31, 2019 | -170.06% |
| May 31, 2019 | -45.61% |
| Feb 28, 2019 | -6.56% |
| Nov 30, 2018 | 371.78% |
| May 31, 2018 | 226,055,312.95% |